Scientists Develop Artificial Intelligence for Mesothelioma Assessment

Scientists in Scotland have developed a prototype imaging system using artificial intelligence that has proven effective with malignant mesothelioma, potentially revolutionizing the way patients will be treated in the future. The pilot program could spark much-needed advances in diagnostics and therapeutics. “Mesothelioma is such a complex, incredibly difficult disease,” Dr. Kevin Blythe, professor of respiratory medicine at University of Glasgow and respiratory physician at Queen Elizabeth University Hospital, told The Mesothelioma Center at Asbestos.com. “This could be a very important step toward helping patients in the future.” The University of Glasgow and Canon Medical Research Europe worked together in developing the novel technology built around artificial intelligence, or AI. The computer software can detect and measure cancer cells more effectively than traditional imaging. It could be used to more accurately – and quickly – assess a mesothelioma patient’s immediate response to drug treatments such as chemotherapy and immunotherapy. AI Could Provide More Personalized Treatment The project, which was launched in 2018, was focused intentionally on mesothelioma, a rare but aggressive malignancy, and one of the most difficult-to-measure with traditional CT scans. Scotland, with a long history of shipbuilding and the use of asbestos in construction, has one of the world’s highest incidence rates of mesothelioma. The findings are ex...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news